What's New
Join Us Online January 31 to February 5
With a steadfast commitment to the health of our members and the safety of their patients, the SMFM Board of Directors and Annual Meeting Program Committee have decided to transition the 2022 Annual Meeting to a fully virtual event.
Read More
Now Accepting Applications
Are you three to seven years post-MFM fellowship and looking to get more engaged with SMFM? Apply for our first-ever Emerging Leaders Program.
Read More
Resources for Maternal-Fetal Medicine
Access our no-cost clinical guidance and patient education.
Read MoreRecent News
- SMFM Supports Use of Paxlovid in Pregnant Patients
- FDA Permanently Removes In-Person Dispensing Requirement for Medication Abortion
- SMFM Partners with RCOG and USASP to File an Amicus Brief in Dobbs v. Jackson Women’s Health Organization
- Remember SMFM Past President, Dr. James Martin
- SMFM Calls on Congress to Pass Legislation that Would Safegaurd Abortion Care
- SMFM Supports NIH Treatment Guidelines for COVID-19, Do Not Withhold COVID-19 Therapies for Pregnant People
- SMFM Supports the Inclusion of Pregnant People in COVID-19 Vaccine Mandates
- Statement of Strong Medical Consensus for Vaccination of Pregnant Individuals Against COVID-19
- SMFM and ACOG Support COVID-19 Vaccination for Pregnant People
- SMFM Supports the Women's Health Protection Act
- Remembering Dr. Jeffrey Greenspoon
- SMFM Thanks the FDA for Lifting the In-Person Dispensing Requirements for Mifepristone During the COVID-19 Pandemic
- SMFM Responds to the FDA and CDC Recommendation to Pause Administration of the Johnson & Johnson (Janssen) Vaccine
- SMFM Applauds Medicaid Extension from 60 Days to One Year Postpartum
- SMFM Applauds Decision to Offer Janssen COVID Vaccine to Pregnant and Lactating People
- SMFM Applauds House Action on Medicaid Extension
- ACOG and SMFM Issue Statement on WHO Recommendations Regarding COVID-19 Vaccines and Pregnant Individuals
- World’s Leading Clinicians and Researchers to Discuss Best Practices for Predicting, Preventing, and Managing Preeclampsia
- SMFM Appoints Christina Wurster as New CEO
- Physicians, Midwives, and Nurses Encourage Health Care Workers to Get COVID-19 Vaccine
- Leaders in Ob-Gyn Release a Statement Supporting Public Health Measures, Including Vaccination. to Combat COVID-19
- SMFM Responds to the FDA’s Decision to Offer the Newly Approved COVID-19 Vaccine to Pregnant and Lactating People
- SMFM Responds to the FDA's Proposal that Makena and Generic Equivalents be Withdrawn from the Market
- SMFM Joins National Leaders in Women's Health to Call on the Office of the Inspector General to Conduct a Thorough Inquiry to Recent Reports of Medically Unnecessary Hysterectomies Performed without Consent in a Facility Operated by the U.S. Immigration and Customs Enforcement
- How to Protect Patient Information in Ultrasound Images that May be Used in Slide Presentations or Video Files
- SMFM and Other National OBGYN Organizations Issue a Joint Statement on Racism in Medicine
Recent Publications
- ACOG-SMFM Practice Advisory: Low-Dose Aspirin Use for the Prevention of Preeclampsia and Related Morbidity and Mortality
- SMFM Special Statement: COVID-19 research in pregnancy: progress and potential
- SMFM Special Statement: Beyond the scalpel: in utero fetal gene therapy and curative medicine
- SMFM Special Statement: Surgical safety checklists for cesarean delivery
- SMFM Fetal Anomalies Consult Series #4: Genitourinary anomalies
- SMFM Consult Series #58: Use of antenatal corticosteroids for individuals at risk for late preterm delivery
- SMFM Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester
- ACOG-SMFM Practice Advisory: Use of Antenatal Corticosteroids at 22 Weeks of Gestation